Monotherapy with TPM was evaluated in an open-label study including 28 adult patients (17 men and 11 with women, aged 22 to 82 years) with recently diagnosed partial epilepsy. After a 2-24 months follow-up (mean 11.5 mths), 16 patients (57%) were seizure-free, 2 (7%) achieved a seizure reduction > 75%, 7 (25%) had a seizure reduction > 50%, and 3 patients (11%) had no improvement. Side effects including weight loss, paraesthesia and sedation were reported in 13 out of 28 patients (46%). Three out of 28 patients (11%) complained of sexual impotence. The results indicate that TPM is an effective and well tolerated drug when utilised in monotherapy.
Topiramate monotherapy in adult patients with recently diagnosed partial epilepsy
Aguglia U
2002-01-01
Abstract
Monotherapy with TPM was evaluated in an open-label study including 28 adult patients (17 men and 11 with women, aged 22 to 82 years) with recently diagnosed partial epilepsy. After a 2-24 months follow-up (mean 11.5 mths), 16 patients (57%) were seizure-free, 2 (7%) achieved a seizure reduction > 75%, 7 (25%) had a seizure reduction > 50%, and 3 patients (11%) had no improvement. Side effects including weight loss, paraesthesia and sedation were reported in 13 out of 28 patients (46%). Three out of 28 patients (11%) complained of sexual impotence. The results indicate that TPM is an effective and well tolerated drug when utilised in monotherapy.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.